• animal models;
  • clinical reports;
  • folate supplementation;
  • mechanisms of NTD;
  • neural tube closure;
  • neural tube defects


  1. Top of page
  2. Abstract

ABSTRACT  Spina bifida, anencephaly, and encephalocele are commonly grouped together and termed neural tube defects (NTD). Failure of closure of the neural tube during development results in anencephaly or spina bifida aperta but encephaloceles are possibly post-closure defects. NTD are associated with a number of other central nervous system (CNS) and non-neural malformations. Racial, geographic and seasonal variations seem to affect their incidence. Etiology of NTD is unknown. Most of the non-syndromic NTD are of multifactorial origin. Recent in vitro and in vivo studies have highlighted the molecular mechanisms of neurulation in vertebrates but the morphologic development of human neural tube is poorly understood. A multisite closure theory, extrapolated directly from mouse experiments highlighted the clinical relevance of closure mechanisms to human NTD. Animal models, such as circle tail, curly tail, loop tail, shrm and numerous knockouts provide some insight into the mechanisms of NTD. Also available in the literature are a plethora of chemically induced preclosure and a few post-closure models of NTD, which highlight the fact that CNS malformations are of hetergeneitic nature. No Mendelian pattern of inheritance has been reported. Association with single gene defects, enhanced recurrence risk among siblings, and a higher frequency in twins than in singletons indicate the presence of a strong genetic contribution to the etiology of NTD. Non-availability of families with a significant number of NTD cases makes research into genetic causation of NTD difficult. Case reports and epidemiologic studies have implicated a number of chemicals, widely differing therapeutic drugs, environmental contaminants, pollutants, infectious agents, and solvents. Maternal hyperthermia, use of valproate by epileptic women during pregnancy, deficiency and excess of certain nutrients and chronic maternal diseases (e.g. diabetes mellitus) are reported to cause a manifold increase in the incidence of NTD. A host of suspected teratogens are also available in the literature. The UK and Hungarian studies showed that periconceptional supplementation of women with folate (FA) reduces significantly both the first occurrence and recurrence of NTD in the offspring. This led to mandatory periconceptional FA supplementation in a number of countries. Encouraged by the results of clinical studies, numerous laboratory investigations focused on the genes involved in the FA, vitamin B12 and homocysteine metabolism during neural tube development. As of today no clinical or experimental study has provided unequivocal evidence for a definitive role for any of these genes in the causation of NTD suggesting that a multitude of genes, growth factors and receptors interact in controlling neural tube development by yet unknown mechanisms. Future studies must address issues of gene-gene, gene-nutrient and gene–environment interactions in the pathogenesis of NTD.


  1. Top of page
  2. Abstract

Neural tube defects (NTD) are a group of heterogenous and complex congenital anomalies of the CNS. Commonly included in this group are anencephaly, spina bifida and encephaloceles. CNS anomalies are by far the most common birth defects and they are surpassed in frequency only by congenital cardiovascular abnormalities (Manning & Archer 2001). Several neural and non-neural malformations are commonly associated with NTD (Gardner 1980; Kallen et al. 1998; Davies & Duran 2003). The most frequent open NTD are anencephaly with cranioschisis and spina bifida aperta with myeloschisis, which arise during the process of neurulation, between the 17th and 30th postfertilization days. NTD arising as a result of a primary failure of the neural tube closure are clinically apparent by being open, i.e. leaving tissues of the unclosed neural tube exposed, in contrast to postneurulation NTD, which are skin covered. Encephaloceles and other skin covered lesions are examples of the post-closure NTD (Campbell et al. 1986; Dias & Partington 2004). The neural tissue in encephaloceles connects to the brain through a narrow stalk. About 70–80% of encephaloceles occur in the occipital region and the nasal and parietal ones are less common (Bozinov et al. 2005).

Anencephaly is a lethal malformation. Individuals with spina bifida have substantially enhanced survival rate thanks to recent improvements in medical and surgical management. However, these patients continue to be at increased risk for morbidity and mortality throughout their life. Treatment does not completely restore normal life. Individuals with lumbosacral spina bifida continue to experience varying degrees of motor and sensory dysfunction of lower limbs and failure of anal and urethral sphincters. Essentially all individuals with thoracic spina bifida and most of the patients with lumbosacral spina bifida are at increased risk for hydrocephalus and Chiari type II malformations (Rintoul et al. 2002; McLone & Dias 2003). Congenital malformations in general and NTD in particular contribute significantly to neonatal mortality during the first year of life (Pinar 2004). Medical care and management of NTD patients require a multidisciplinary team with special skills and cost substantial amounts of money. Periconceptional counseling can result in significant savings in life time costs for NTD affected individuals (de Weerd et al. 2004). A thorough understanding of the normal development of the neural tube, and pathophysiology, prognosis and susceptible periods of NTD are particularly important for planning strategies for effective prevention of NTD. This review endeavors to outline our current understanding of normal neural tube development and alludes to possible etiology, pathogenesis and prevention of NTD.

Embryonic development of the neural tube

Our current knowledge of the morphological and molecular mechanisms of neural tube development stems largely from experiments in chick and mouse embryos (Juriloff et al. 1991; Fleming et al. 1997; Schoenwolf & Smith 2000; Colas & Schoenwolf 2001, 2003; Lawson et al. 2001; Schoenwolf 2001; Ybot-Gonzalez et al. 2002; Copp et al. 2003). In recent years, there has been some important advancement in our understanding of such complex issues as how different signaling pathways converge in the induction of neural crest cells, their sequential migration-activation process, actual migration and transformation into mesenchyme and their diverse morphologic derivatives in Xenopus, chick and mouse embryos. A host of genes have been implicated in the networking of crest cell induction, migration, specification, and differentiation (Gammill & Bronner-Fraser 2002, 2003; Knecht & Bronner-Fraser 2002; Basch et al. 2004; Farlie et al. 2004). However, as far as human neural tube is concerned, only a cursory idea of the sequence of its normal morphologic development is available. Fundamental questions of molecular and cellular mechanisms of neural tube closure in human embryos remain largely unanswered (O’Rahilly & Muller 1989, 1994, 2002).


The initial step in neural tube development is a characteristic thickening of the ectoderm from the level of the primitive node of Hensen caudally to the prochordal plate rostrally at the beginning of the 3rd week of embryonic life. This slipper-shaped structure is called the neural plate. Studies in xenopus embryos led to the belief that the ectoderm is preprogrammed towards a neural fate and endogenous BMPs (bone morphogenetic proteins) inhibit this default system. However, neural induction in higher vertebrates appears to be a more complex process, in which inhibition of BMP-4 involves an intricate interplay of FGF (fibroblast growth factors), Noggin, Chordin, Wnt-3, β-catenin and possibly calcium transients (Jessell & Sanes 2000; Linker & Stern 2004; Webb et al. 2005). These genes appear to be conserved across species (‘Mice are people’). Differential rates of cell proliferation, cell movement and changes in cell shape in the neural plate result in the formation of neural groove in the median plane and neural folds on either side. By complex processes of cell-shaping (apicobasal elongation, apical narrowing and basal expansion), cell movement and cell adhesion, aided by the forces provided by the underlying mesenchyme and overlying surface ectoderm, the neural folds elevate themselves, converge along the dorsal midline and fuse with each other to form the neural tube (Colas & Schoenwolf 2001). Fusion also involves the surface ectoderm at the edges of the neural folds dorsal to the neural tube. Neural crest-derived ectomesenchyme in the cranial region and somitic mesenchyme in the trunk region spread around the neural tube under the surface ectoderm and form the primordia of the meninges, axial skeleton and muscles attached to the axial skeleton.

Median and dorsolateral hinge-points

Preceding closure, the initially elliptical neural plate becomes elongated which results in an elongated keyhole-shaped structure, with a broad rostral and a narrow caudal region. This dramatic change in shape of the neural plate results from convergent extension (CE) and planar cell polarity (PCP) and involves a number of genes (Torban et al. 2004). The PCP and CE pathways function to establish polarized tissue patterns as well as to coordinate complex cell migrations and asymmetric cell division during gastrulation and neurulation. CE in neurulation is a medially directed movement of cells with intercalation in the midline, which results in both lengthening of the neural plate craniocaudally and relative narrowing transversely. Change in shape is accompanied by a median bending in the neural plate first in the area of future cervical region, called the median hinge-point (MHP) and one on each side, known as the dorsolateral hinge-point (DLHP) along the junction between neuroectoderm and surface ectoderm. Cells in the MHP of chick embryos are predominantly wedge-shaped, occupy a median furrow and remain attached to the notochord/notochordal plate (Smith et al. 1994). Coordinated changes in cell-shape instruct hinge-point formation (Wallingford et al. 2002). Changes in cell-shape associated with DLHP also include an apical narrowing and basal widening of neuroepithelial cells with cytoskeletal protein concentration under the apical membrane (Hildebrand & Soriano 1999). Cytoskeletal integrity of the neural plate cells plays a major role in the process of hinge point formation and convergence of the neural folds in the dorsal midline.

In loop-tail (Lp) mouse embryos, disruption of the process of CE results in a neural plate, which has an abnormally broad floor plate with no MHP. The elevated neural folds remain too far apart to contact with each other and the entire neural tube remains unclosed (craniorachischisis). They carry a point mutation in Vangl2, a gene known to control PCP in Drosophila. Both crash and circletail mutants resemble Lp phenotypically. They carry a mutation in Celsr1 and Scrb1 genes, respectively. Doudney and Stanier (2005) recently demonstrated a genetic interaction between all these three genes, where double heterozygotes exhibit the same homozygous phenotypes. Circletail and Loop-tail mutants were previously shown to interact and result in a phenotype similar to that of individual homozygotes (Murdoch et al. 2003). Viewed together, these studies show that interactions between independent recessive alleles may explain some of the complex inheritance in human NTD. They also indicate that CE and PCP are crucial developmental mechanisms that control neural tube closure in mammalian embryos. In wild type embryos, Shh expression remains high, while in the Ltap/Lpp1 the expression is reduced in the floor plate region at the time of neural tube closure. However, in the Shh–/– embryos, Ltap/Lpp1 expression remains high, the floor plate is indistinct and midline structures are defective, whereas a low expression of Ltap/Lpp1correlates with broad floor plate. These embryos subsequently develop defects of ventral midline cells of the neural tube and cyclopia indicating that Shh plays a strong role as an extracellular signaling molecule during development (Chiang et al. 1996). In shroom (shrm) mutation, cytoskeletal polarity within the neuroepithelium is perturbed and both DHLP formation and convergence of the neural folds are severely affected resulting in exencephaly, acrania, facial clefting and spina bifida (Hildebrand & Soriano 1999). Dorsal elevation of the edges of the neural plate into neural folds is largely aided by significant proliferation and expansion of the underlying mesenchyme. Brook et al. (1991) hypothesized that an enhanced axial curvature of the posterior neuropore (PNP) retards the elevation and convergence of the neural folds and thereby delays PNP closure in curly tail mouse embryos. In an elegant study, Peeters et al. (1998) compared caudal axial curvature and closure rates of PNP in chick, rabbit, mouse and human embryos at developmentally comparable stages and adduced evidence that a decrease in axial curvature due to unbending is accompanied by an increased PNP closure rate in these species. PNP closure process is fastest in chick embryos because they do not have an axial curvature. Decrease in axial curvature and embryonic body elongation in the caudal region also possibly involve changes in cell shape, cell proliferation and cell rearrangement.

Neural tube closure

Morphologically closure of neural tube involves apposition of the dorsal edges of the neural folds along the median plane, epithelial breakdown at contact sites accompanied by apoptosis and merger of the neuroepithelium. Studies in animal embryos indicate that Shh emanating from the notochord and region-specific expression of Gli1, Gli2 and Gli3 play major roles in the spatially and temporally controlled processes of neural fold fusion. Gli1 is expressed in the midline neural plate cells and in immediately adjacent cells. Gli2 and Gli3 are expressed in all but midline neural plate cells. Gli1 mediates Shh signaling. Shh represses Gli2 transcription. Gli3 and Shh repress each other. Gli1 induces ventral forebrain neuronal differentiation. In contrast, ventral spinal motor neurons are induced by Gli1 and Gli2. Thus Gli proteins also integrate positional information and neuronal type-specific differentiation in the CNS (Lee et al. 1997; Ruiz i Altaba 1998; Stamataki et al. 2005).

Theories of neural tube closure

Five sites of initiation of neural fold-fusion

The ‘zipper theory’ according to which the first site of contact between the dorsal edges of the neural folds occurs in the cervical region and fusion progresses cranially and caudally until the entire tube is formed, is no longer tenable. Multiple sites of initiation of neural folds fusion was reported in the mouse by Sakai (1989) and later by others (Juriloff et al. 1991; Golden & Chernoff 1993). Van Allen et al. (1993; Van Allen 1996) proposed a similar multisite closure model for the human embryos (Fig. 1). Their theory was based on the observations on therapeutic abortuses and still born fetuses who had fusion defects at different sites along the neural axis. According to their postulate (Van Allen et al. 1993; Van Allen 1996), a variety of NTD could be classified by closure sites where closure-failure occurs. Consistent with this model, the first site of contact between the cranial neural folds, known as closure 1, occurs at the presumptive rhombencephalon-spinal cord junction and progresses bidirectionally. Closure 2 starts at prosencephalon-mesencephalon junction and also extends rostrally and caudally. Closure 3 begins at the rostral tip of the neural plate adjacent to the stomodeum and progresses caudally to meet closure 2. Closure 4 starts between closure 1 and closure 2 over the rhombencephalon and completes the closure of the cranial portion of the neural tube from which the brain develops. Closure 5 starts at the caudal end of the neural groove and proceeds cranially to meet closure 1 thus completing closure of the spinal portion of the neural tube.


Figure 1. (A) Extrapolated from mouse to human embryos, Van Allen’s (1996) model has 5 sites of initial fusion of neural folds (‘closure’ 1–5): (1) Rhombencephalon-spinal cord junction; (2) Prosencephalon-mesencephalon junction; (3) Rostral extremity of neural folds; (4) Caudal end of rhombencephalon; (5) Between L2 and S2. Fusion spreads bidirectionally from Closure 1 and 2 and unidirectionally from Closure 3, 4 and 5. (Van Allen [1996]. Kind permission of John Wiley & Sons.)

Download figure to PowerPoint

Three sites of initiation of neural fold-fusion

Van Allen and colleagues (Van Allen et al. 1993; Van Allen 1996) and Seller (1995) were possibly the first to give a clinical flavor to the existence of more than one initial site of neural fold fusion in human embryos. However, their five-site theory was not supported by other contemporary studies in mouse embryos (Juriloff et al. 1991; Copp & Bernfield 1994) and by observations on human embryos (Sulik & Sadler 1993). For instance, mouse embryos are found to vary widely in the timing and location of sites of initiation of neural fold fusion (Copp & Bernfield 1994; Fleming & Copp 2000). The cranial neural tube only presents three closure sites: Site 1 and Site 3 are similar to those of Van Allen et al. (1993). Site 2 appears to vary in position along the rostrocaudal axis in inbred and outbred strains and backcrosses of splotch (Sp2H) to DBA2 and NZW (Fig. 2). Generally strains with a morphological shift of Site 2 to more rostral positions have a greater predisposition to NTD than those with more caudal positions (Fleming & Copp 2000). Closure 2 is absent in exencephaly prone SELH/Bc strain.


Figure 2. Mouse models (Juriloff et al. 1991; Copp & Bernfield 1994) have 3 sites of initial fusion of neural folds: Site 1 and Site 3 are similar to those of Van Allen (1996). Site 2 appears to vary in position (block dots) along the rostrocaudal axis in inbred and outbred strains and backcrosses of splotch (Sp2H) to DBA2 and NZW, generally more rostral positions predisposing to NTD and caudal positions being resistant to NTD (Fleming & Copp 2000). (Copp & Bernfield [1994]. Kind permission of Lippincott Williams & Wilkins.)

Download figure to PowerPoint

Nakatsu et al. (2000) studied recently 68 normal embryos of Carnegie stages 10–12 and 98 embryos of Carnegie stages 11–23 with NTD stored at the Congenital Anomalies Research Center in Kyoto. They observed three sites: Site A, Site B and Site C (Fig. 3). The situations of Site A and Site C closely resemble Closure 1 and Closure 3, respectively, of Van Allen et al. (1993). Fusion of neural folds at Site A begins in the upper cervical region at late Carnegie stage 10 and progresses rostrally and caudally. Site B of neural fold-fusion is recognized in a few of the Carnegie stage 10 embryos at the rhombencephalon-mesencephalon junction and extends bidirectionally and rather rapidly. Therefore, the opening between site A and site B is so small that it possibly does not last longer than a few hours. Van Allen et al. (1993) on the other hand assumed Closure 2 to initiate at prosencephalon-mesencephalon junction, particularly because their postulate was based on mouse studies. Site C of Nakatsu et al. (2000) initiates at the rostral tip of the neural groove in Carnegie stage 11 embryos and spreads caudally over the prosencephalon. This one meets with the rostral extension of neural fold-fusion from site B and completes the closure of the rostral neuropore, the opening between the rostral portions of neural folds of the prosencephalon (Fig. 3). In the meantime, fusion between neural folds from site A progresses caudally all the way to the caudal neuropore in the lumbosacral region. The neural groove becomes progressively shallow toward the caudal neuropore, which is completely closed at Carnegie stage 12. However, Closure 4 and Closure 5 of Van Allen et al. (1993) were not observed. Also fusion starting at Site A was found to be bidirectional; its caudal extension continued to the entire length of the spinal portion of the primary neural tube.


Figure 3. The Kyoto Collection of Human Embryos of Carnegie Stages 10–12 present 3 sites of initial fusion of neural folds (Nakatsu et al. 2000). Site A initiates at upper cervical region, Site B at rhombencephalon-mesencephalon junction and Site C at the rostral end of the neural groove. Fusion spreads bidirectionally from Site A and B and caudally from Site C. The caudal fusion from Site A spreads towards the caudal neuropore and involves the entire spinal portion of primary neural tube. Secondary neurulation from the neural cord forms the distal neural tube which connects with primary neural tube at S2. (Nakatsu et al. [2000]. Kind permission of Springer Science and Business Media.)

Download figure to PowerPoint

Two sites of initiation of neural fold-fusion

On the other hand, O’Rahilly and Muller (2002) observed only two sites of initiation of neural folds-fusion by graphic reconstruction of paraffin sections of Carnegie collection of human embryos of Stages 8–13: Site α in the region of the rhombencephalon and Site β in the region of the rostral tip of the prosencephalon (Fig. 4). The earliest of their embryos with fusion of neural folds had 4 pairs of somites. Therefore, the initial fusion must have occurred in their embryos in the occipital rather than in cervical region of the neurotaxis. Fusion of neural folds starting at Site α was seen to progress bidirectionally and that at Site β caudally. The fusion of the surface ectoderm was seen to occur first followed by fusion of the neural folds thus implying a significant role for the surface ectoderm. Accessory sites of neural fold apposition were observed along the neural axis independently and simultaneously but they were highly inconsistent in incidence, limited to Stage 10 and did not follow a specific pattern. Therefore, they interpreted Nakatsu et al.’s (Nakatsu et al. 2000) Site B as an example of ‘accessory loci’ which had not ‘been overlooked by previous investigators’. That the fusion of neural folds in the region between Site A and Site B (of Nakatsu et al. 2000) is too rapid might be the reason why O’Rahilly and Muller (2002) did not observe site B in their embryos. The inference from these studies is that the phenomenon of multisite closure of developing neural tube, extrapolated directly from mouse embryos is of limited clinical significance because the number of initial fusion sites is possibly limited to 2 or 3 in human embryos (Nakatsu et al. 2000; O’Rahilly & Muller 2002). Different combinations of closure failure defects reported in the literature possibly suggest a causal heterogeneity of NTD origin (Martinez-Frias et al. 1996). The 2 or 3 fusion sites (and the occasional accessory sites) observed in human embryos are adequate to interpret logically most of the NTD resulting from a primary closure failure of the neural tube. The reported differences in the number of initial sites of contact between neural folds in human embryos is possibly a reflection of the fact that: (a) neural tube closure is a rapid process; (b) neural tube closure is a more complex process than what we currently understand; (c) the number of human embryos of neurulation stage available for study is inadequate; (d) we need to observe more embryos to fill the gaps in our knowledge; and (e) since severely dysraphic embryos die early in utero, one doesn’t get to see all theoretically possible combinations of non-contiguous malformations of the CNS at or after term.


Figure 4. Graphic reconstruction of the Carnegie Collection of human embryos of Stage 8–13 reveal mainly 2 fusion sites: Site α and Site β. Site α initiates at the caudal rhombencephalic level and Site β at the rostral extremity of the neural plate. Fusion of neural folds spreads from Site α caudally to the caudal neuropore and rostrally to the caudal limit of fusion from Site β to close the rostral neuropore (O’Rahilly & Muller 2002). Accessory sites of neural fold fusion are sometimes seen in the cervical, rhombencephalic and thoracic regions (not illustrated). (O’Rahilly & Muller [2002]. Kind permission of John Wiley & Sons.)

Download figure to PowerPoint

Species variation in neural folds fusion

Neural tube closure has been investigated extensively in chick (Van Straaten et al. 1996), mouse (Sakai 1989; Juriloff et al. 1991; Golden & Chernoff 1993; Juriloff & Harris 2000), rat (Edwards 1968), hamster (Marin-Padilla 1970), rabbit (Peeters et al. 1998) and pig (van Straaten et al. 2000) embryos. Not only are there a certain degree of homologies between species but also there are noticeably significant species and strain differences in the number of sites of initiation of closure, direction of fusion progression, and sequence of onset of fusion points. Accessory sites of neural fold fusion reported occasionally (O’Rahilly & Muller 2002) need to be investigated further because they might help us explain why sometimes both rostral and caudal dysraphic spinal NTD develop in the same embryo. Neural crest-derived ectomesenchyme in the cranial region and somite derived paraxial mesoderm in the spinal portion have both mechanical and inductive influence on the neural plate differentiation, neural fold elevation and subsequent fusion of the neural folds and surface ectoderm of either side. This influence is apparent from the fact that parts of the axial skeleton are grossly malformed when neural tube fails to close in human and animal embryos (Padmanabhan & Hameed 1985; Padmanabhan 1989; Marin-Padilla 1991).

Secondary neurulation

The spinal portion of the primary neural tube from which most of the spinal cord develops ends approximately at the level of somite 31, the future sacral segment 2 (S2) (Muller & O’Rahilly 1987). The caudal neuropore closes during Carnegie Stage 12 when there are approximately 25 pairs of somites. The most distal segment of the spinal cord develops by a process, called secondary neurulation from the caudal eminence (not to be confused with the ‘tail bud’ of chick embryos). Caudal eminence comprises pluripotent cells derived from the regressing primitive streak. These cells give rise to the neural cord, a portion of the hindgut, caudal somites, caudal notochord, etc. (O’Rahilly & Muller 1989). The mesenchymal neural cord then becomes an epithelial cord, acquires a lumen and connects itself with the primary neural tube and forms the remaining sacral and coccygeal segments of the spinal cord. The uncertainty of our knowledge of caudal neural tube development is largely compounded by a paucity of properly preserved human embryos of the stages during which this part of the tube develops. In a recent study on the Kyoto collection of human embryos, Saitsu et al. (2004) observed no direct extension of the lumen of the primary neural tube into that of the neural cord. Multiple cavities were observed as was the case in RA-treated mouse embryos (Padmanabhan 1998; Shum et al. 1999). These cavities possibly coalesce to form the definitive lumen of the caudal neural tube. The entire neural tube formation is completed during Carnegie stage 11 and 12, within a span of about 10 days starting from postfertilization day 18. This critical window of neural tube closure is the period during which any primary failure of neural tube closure must occur. Additional studies are required to clarify mechanisms of caudal neural tube formation in order to understand why this part of the tube is frequently involved in NTD, the consequences of which seem to vary in severity and clinical manifestation. One recent fate mapping study in chick embryos suggests that the neural plate gives rise to both the primary and the secondary neural tubes and that the distal part of the axis which forms last suffers most as a result of perturbation of axis elongation and mesodermal tissue deficiency possibly caused by altered expression of T-box, Wnt and HLXB9 (Catala 2002).

Neural tube defects

Pathogenetic mechanisms of NTD

According to Von Recklinghausen (1886), arrest of closure of the embryonic neural tube is the mechanism of open NTD - hence the term ‘dysraphia’. Morgagni (1769), on the other hand, believed that increased intraventricular pressure due to excessive production of cerebrospinal fluid (hydrops cerebri et medullaris) might lead to reopening of an already closed neural tube resulting in NTD (reviewed Padmanabhan 1984). Although most of the NTD are often reported to result from a primary failure of the embryonic neural tube to close, there is some compelling clinical and experimental evidence in support of the possibility of a closed neural tube secondarily reopening, resulting in NTD (Gardner 1980; Padmanabhan 1984, 1988, 1989; Padmanabhan & Hameed 1985; O’Rahilly & Muller 1988, 2002; Padmanabhan 1990a,b; Sulik & Sadler 1993; Van Allen et al. 1993; Van Allen 1996; Ikenouchi et al. 2002). Both experimental and human embryo studies indicate that post-closure defects are of relatively late onset (Padmanabhan 1990a,b; Ikenouchi et al. 2002) and might occur over an extended period of time during development. Most textbooks of embryology and NTD review papers (Van Allen et al. 1993; Van Allen 1996; Copp et al. 2003; Cabrera et al. 2004) appear to describe NTD as single developmental abnormalities and seek pathogenetic mechanisms as a direct result of closure failure of the neural tube rather than seeing them as a part of a spectrum maldevelopment affecting the neural tube and associated meninges and axial skeletal structures. Depending on the timing of onset during development, NTD affect not only different regions of the neural tube but several non-neural organs (Gardner 1980; Seller & Kalousek 1986). Myelomeningoceles are almost always associated with Chiari II malformations (McLone & Dias 2003). In an elegant study, Seller and Kalousek (1986) compared the frequency and pattern of isolated NTD and those of the NTD associated with other abnormalities. They note that significant clustering of developmental defects are associated with total craniorachischisis and upper thoracic spina bifida, less frequently with anencephaly and lumbosacral spina bifida and never with sacral spina bifida. This definitive pattern possibly implies a connection between the mechanisms by which NTD and associated anomalies develop. They postulate that additional abnormalities arise as a result of mechanical induction by the specific disturbance of the neural tube and its surrounding tissues. The developmental disruption at neurulation is more far reaching in NTD with associated anomalies than in isolated NTD.

Incidence and prevalence of NTD

The incidence of open NTD is reported to vary in different parts of the world depending on the geographic region, seasons at conception, gender of the affected infants, ethnicity, and socioeconomic status of the parents, maternal age and parity (Laurence et al. 1968; Xiao et al. 1990). The occurrence of NTD in abortuses and stillbirths is manifold higher than that in otherwise normal population (Nishimura et al. 1987; Shiota et al. 1987). A declining trend in NTD frequency has been reported recently in some areas, while the incidence has remained stable in other parts of the world (McDonnell et al. 1999; Chan et al. 2001; Busby et al. 2005). While the reason for this decrease is unclear, there seems to be some effect from prenatal diagnosis, selective termination of NTD pregnancies, genetic counseling, and possibly nutritional supplementation during pregnancy (Lemire 1988a,b; EUROCAT Working Group 1991; Stevenson et al. 2000; Chan et al. 2001; Williams et al. 2005). There is some robust data which indicates that the European countries vary widely in the availability and use of prenatal screening and its quality, as well as the ‘culture’ in terms of the decision to continue or terminate an NTD pregnancy. This necessarily contributes to notable variations between countries in childhood prevalence and cost to health care services of congenital anomalies (Garne et al. 2005).

Etiology of neural tube defects

As outlined above, development of the neural tube is a multi-step process strictly controlled by genes and modulated by a host of environmental factors. It involves gene–gene, gene–environment and gene–nutrient interactions. Despite years of intensive epidemiological, clinical and experimental research, the exact etiology of NTD remains rather complex and poorly understood. Genetic and environmental factors contribute to NTD. However, it is generally agreed that most NTD cases are of multifactorial origin, having a significant genetic component to their etiology that interacts with a number of environmental risk factors (Volcik et al. 2002a; Frey & Hauser 2003).

Genetic causes of neural tube defects

There are quite a few lines of evidence in favor of a strong genetic contribution to the causation of NTD in a proportion of all NTD prevalence. A compelling piece of evidence is the observation that NTD show familial aggregation, although they do not follow a strict Mendelian pattern of inheritance. The recurrence risk for NTD in siblings of patients with myelomeningocele is reported to range from 2 to 5% (Sebold et al. 2005). The incidence of NTD among first and second degree relatives of affected infants appears to be significantly higher than that reported to involve general population. Females and monozygotic twins appear to be particularly prone to NTD (Windham & Sever 1982). The prevalence of both encephalocele and anencephaly are increased, whereas spina bifida is decreased in twins as compared to singletons suggesting that twins and singletons vary in their response to etiologic factors and that there may be different factors influencing development of specific types of NTD. The etiology could be different in areas of high and low prevalence.

Several chromosomal and single-gene disorders have been reported to be associated with NTD (Online Mendelian Inheritance in Man 2000). Spina bifida occurs more frequently in autosomal trisomies. Animal studies have shown that there are as many as 100 mutant genes affecting neurulation and almost all of them have their homologs in humans (Juriloff & Harris 2000; Klootwijk et al. 2004). NTD are associated with several single gene disorders (e.g. cerebrocostomandibular syndrome. Fraser syndrome, Meckel–Gruber syndrome, Waardenburg syndrome). However, so far we know of no single gene, which is solely responsible for NTD in humans. It must be admitted that the genetics of human NTD is complex and poorly understood. One of the reasons for this is the paucity of families with several NTD-affected members. Perinatal mortality and morbidity of individuals with NTD are significant and the reproductive fitness of the survivors is poor. In addition to chromosomal anomalies, congenital heart diseases, certain skeletal dysplasias, NTD contribute significantly to neonatal deaths (Petrini et al. 2002; Pinar 2004). Anencephalic offspring surviving to term die at birth or soon after (Pinar 2004) thus a pattern of inheritance cannot be established.

Anencephaly is reported to be particularly more prevalent in certain communities with a high rate of consanguinity (Zlotogora 1997a,b; Al-Gazali et al. 1999). Spontaneous abortuses with NTD have a significant association with chromosomal aberrations suggesting a genetic component to their etiology (Coerdt et al. 1997; McFadden & Friedman 1997). Spontaneous abortions are often followed by term infants with NTD in the subsequent pregnancies (Carmi et al. 1994). Despite the declining prevalence rates of NTD in many parts of the world, there seems to be no decline in NTD recurrence within affected families (Czeizel & Metneki 1984). A Hungarian study (Papp et al. 1997) shows a recurrence risk of 3.47% and 2.95% for NTD and hydrocephalus, respectively, after excluding the obviously monogenically inherited cases from a total of 1285 isolated and 177 multiple forms of craniospinal anomalies. The risk was seen to be influenced mainly by anatomical severity of the malformation, degree of relationship and the number of affected relatives in the family (Papp et al. 1997).

Understandably anencephalic fetuses are so severely malformed that they do not survive to establish a parent-child transmission. The genes regulating normal development of the neural tube have not been delineated definitively and therefore one does not know what genes to look for in index children. The recurrent risk for anencephaly in siblings ranges from 2 to 5%, much lower than the 25 and 50% expected under strict Mendelian recessive and dominant inheritance, respectively. However, there are some studies that report anencephaly involving autosomal recessive genes, with some environmental influence (Demenais et al. 1982; Shaffer et al. 1990; Zlotogora 1995). The timing and nature of such influence might explain why a significant number of recurrences involve an NTD phenotype that is different from the case phenotype. An autosomal dominant gene has been implicated in a familial aggregation of spina bifida occulta (Fineman et al. 1982). Based on the knowledge that BMP4 and its specific inhibitor NOG are involved in normal neural tube development in mice, Felder et al. (2002) performed a single-strand conformation analysis mutation screen for both genes in 179 German spina bifida patients. There were four cases of missense mutations in BMP4 and one in NOG. It was suggested that these mutations acted in concert with other gene variants and contributed to susceptibility for NTD in these patients (Felder et al. 2002). Further studies involving larger affected populations are required before some meaningful conclusions can be drawn on the heritability of open NTD. Meckel–Gruber syndrome, which is a rare autosomal recessive disorder, has an encephalocele component in addition to several severe CNS malformations (Ahdab-Barmada & Claassen 1990). Patients with interstitial deletion of chromosome 2 (2q35–36.2), including the PAX3 gene (Waardenburg syndrome-type 3), are reported to have myelomeningocele (Nye et al. 1998). Waardenburg syndrome (WS) is a pleiotropic, autosomal dominant condition with variable penetrance and expressivity. Therefore it is not surprising that PAX3 mutations have been associated with only a subset of WS patients. It is also worth noting here that not all PAX3 mutations are associated with a Waardenburg phenotype and that additional regional loci may modify or regulate the PAX3 locus and/or the development of a Waardenburg phenotype (Pasteris et al. 1993).

Twinning appears to be associated with a significant increase in NTD over the rest of the population (Windham & Sever 1982). There is an increased frequency of twinning in the near relatives of probands with upper NTD and upper NTD families with twins have a higher rate of NTD siblings than do families without twins (Garabedian & Fraser 1994). Monozygotic twinning is more frequently concordant for congenital anomalies than dizygotic twinning (Windham & Sever 1982). Some genetic or environmental factors were thought to make NTD families susceptible to twinning (Garabedian & Fraser 1994). Since supplemental folate (FA) protects some fetuses against NTD, it was suggested that FA might play some role in twinning. However, there is no robust evidence in support of the presence of an increased frequency of twins following FA supplementation (Li et al. 2003).

Consanguinity appears to allow clustering of liability genes each of which possibly contributes to NTD in some way (Carter et al. 1968). A recent study on a highly consanguineous community (Al-Gazali et al. 1999) indicates that whereas some rare syndromes occur relatively more frequently, NTD per se do not occur at a high frequency in this population.

Environmental causes of neural tube defects

Physical and chemical environment

Differential incidence of NTD depending on the geographic areas, socioeconomic status of the parents, seasonal variations, discordance in monozygotic twinning, etc. point to the possibility of an environmental component to the etiology of NTD. Alternatively, these variations in frequency might point to possible gene–environment interactions at critical stages of neural tube development. Epidemiological and experimental studies on NTD provide some evidence that a host of physical agents (e.g. X-irradiation, hyperthermia, stress), drugs (e.g. thalidomide, folate antagonists, androgenic hormones, antiepileptics such as valproate and carbamazepine, and hypervitaminosis A), substance abuse (e.g. alcohol), chemical agents (e.g. organic mercury, lead), maternal infections (e.g. rubella, cytomegalovirus, Toxoplasmo gondii, syphilis), maternal metabolic conditions (e.g. phenylketonuria, diabetes mellitus, endemic cretinism), etc. are capable of causing congenital malformations of the central nervous system structures (Shenefelt 1972; Wilson 1973; Committee on Developmental Toxicology, National Research Council 2000; Shepard et al. 2002; Ray et al. 2004). Parental socioeconomic class, occupation (e.g. nursing, processing food and beverages, farming, textile dye and leather industries, spraying pesticides) and possible occupational exposure to noxious agents such as organic solvents, anesthetic agents, sterilants, viruses, pesticides, paints, X-radiation, have been reported to be associated with a high risk for NTD (Brender & Suarez 1990; Matte et al. 1993; Sever 1995; Shaw et al. 2002; Blanco Munoz et al. 2005). Maternal health status (e.g. obesity, diabetes) has been attributed to enhance the risk for NTD in the offspring (Ray et al. 2004; Dietl 2005). Such studies need to be extended so as to include a large and statistically acceptable number of cases for further confirmation of the conclusions made thus far. The antenatal screening study (Ray et al. 2004) should include women with spontaneous pregnancy loss which is known to be associated with a high incidence of NTD. It is important to point out here that contrary to frequent claims, it is CVS anomalies and not NTD which are more common in infants of diabetic mothers (Schaefer-Graf et al. 2000)). This observation is in agreement with our diabetic rat study (Padmanabhan & Al-Zuhair 1988)

Ambient exposures

Ambient exposures include exposure to airborne chemicals living in close proximity to their source (e.g. polyvinyl chloride) (Theriault et al. 1983; Uzych 1988) and toxic wastes from landfill sites located within 3 km of residence (Croen et al. 1997; Marshall et al. 1997; Dolk et al. 1998). Some studies have reported negative results for maternal exposures from landfill sites located at distance of over 3 km (Vrijheid et al. 2002; Morris et al. 2003). Landfill sites contain a range of chemicals which might further contaminate surface and ground water, plants and cattle grown in the vicinity and the air. Therefore, it was not possible for these studies to determine the type and amount of exposure. Additional confounders include the socioeconomic status of mothers living in this area and potential exposure to other drugs and chemicals outside the sites in the background. Maternal exposure to contaminated drinking water with carbon tetrachloride, trichloroethylene, and benzene has been reported to confer an increased risk of NTD and major cardiac defects (Bove et al. 1995). Methods of assessment and misclassification of pregnancy outcomes are possibly the reason for certain of the discrepancies observed across studies.


Hyperthermia has been suspected to be a neuroteratogen for human embryos by an analogy from laboratory investigations. Results of in vivo and in vitro experimental studies on guinea pig, rat, mouse and chick embryos indicate that the neural tube is particularly sensitive to heat stress. Enhanced core body temperature appears to interfere with several critical developmental events such as cell proliferation, migration, differentiation and apoptosis. The response to heat appears to depend on the species, strain, embryonic developmental stage at which heat exposure occurs, dose and duration of exposure (Edwards et al. 1995, 2003). A similar dose–response relationship has not been established for human embryos. Direct extrapolation of animal data to human embryos is not possible. However, a recent meta-analysis indicates that maternal hyperthermia during gestation is associated with an enhanced incidence of neural tube defects (odds ratio 1.95) showing that the neural tube is heat-sensitive in human embryos too (Moretti et al. 2005) Maternal exposure to non-physiological levels of high temperature (e.g. in sauna, hot water tub) and treatment with antipyretic agents during critical period of neurulation have been found to increase the risk of NTD in the offspring (Suarez et al. 2004). In addition to parental and embryonic genetic susceptibilities, the actual level of exposure, gestational stage at which the exposure occurred and the genotypes of the parents and offspring might have contributed substantially to the variabilities between studies. It is important to point out here that NTD are of heterogenous nature with regards to their etiology. The pathogenetic mechanisms of all CNS anomalies are not the same and different anomalies might be related to not only the agent to which exposure occurs but also to the pathogenetic differences between anomalies (e.g. anencephaly, spina bifida and encephaloceles). Future studies must address these variables in the context of evaluating NTD incidence and risk factors.

Environmental and genetic interactions

A host of suspected teratogens is also available. These agents might be teratogenic given the susceptible genetic background. Since NTD are of multifactorial origin, an understanding of the possible interaction-effects of teratogens with susceptible genes is of particular interest. One of the practical ways to look at this issue is to use animal models in which the confounding variables inherent to human studies could be maximally avoided while studying the pathogenetic mechanisms. Currently there are over 100 mouse models of NTD. Most of these mouse NTD phenotypically resemble human NTD to a large extent (Harris 2001). Among mouse and human homolog genes may be genes with alleles of partial function, which might combine to induce the risk of some of the common non-syndromic NTD. In this context, it needs to be understood that in addition to gene–gene interactions, there might also be instances where susceptible genes interact with teratogens thus enhancing the NTD risk (Finnell et al. 2004). These interactions might contribute to the seasonal or geographic variations often attributed to NTD incidence. Of the numerous opportunities that exist for interactions, at least some are important from a teratologic point of view. For instance, food and beverages contain ingredients which might interact, particularly with orally administered-drugs via drug-metabolizing enzymes. Foods containing phytochemicals and herbal supplements have the greatest potential to induce enzymes, which could affect the bioavailability of the active molecules in the drug necessitating dosage adjustments (Harris et al. 2003). Dietary modifications are also known to alter the plasma concentrations of drugs. Dietary habits and nature of the diets have ethnic and geographic variations. Thus exposures to a drug considered safe in a given dosage for use in pregnancy in a given situation might reach teratogenic concentrations in some pregnant women.

Nutritional factors

The role of maternal nutrition on normal fetal development and growth is well known. Nutrional status of the parents can affect the quality of the gametes and fertilization capacity. There are some reports that suggest that polymorphisms in folate metabolizing enzymes might be associated with enhanced likelihood of meiotic non-disjunctions (O’Leary et al. 2002; Wong et al. 2002). Genotype of the embryo and nutrient environment of the mother play decisive roles in growth and development of the embryo. With the discovery that periconceptional FA supplementation has beneficial effects in terms of reduction of 50–70% in the occurrence of NTD (MRC Vitamin Study Research Group 1991; Czeizel & Dudas 1992) and substantial reduction in the incidence of several other non-neural anomalies, enthusiasm for search for the mechanisms of FA-responsiveness to NTD increased. As a result, a number of FA-related genes have been studied in some detail. The following genes in the folate metabolic pathway are noteworthy because they have been studied more extensively than others.

  • • 
    5,10-methylene tetrahydrofolate reductase (MTHFR);
  • • 
    Methylene tetrahydrofolate dehydrogenase (MTHFD);
  • • 
    Cystathionine β-synthase (CBS);
  • • 
    Methionine synthase (MTR);
  • • 
    Methionine synthase reductase (MTRR);
  • • 
    Folate Receptor α and β.
MTHFR (5, 10-methylene tetrahydrofolate reductase)

C677T and A1298C are two well known mutations of MTHFR gene implicated in human NTD. These mutations have been observed in variable per centage of individuals in different populations both with and without NTD. Whitehead et al. (1995) observed the C677T thermolabile variant gene in 18% of spina bifida patients and 6% of control population in Ireland and indicated the possible contribution of this mutation to NTD risk. van der Put et al. (1995) showed the presence of C677T mutation in 15% of spina bifida patients and 16% of mothers and 10% of fathers of patients as well as 5% of controls in the Netherlands. These results would suggest that a ‘suboptimal maternal folate status imposes a biochemical stress on the developing embryo, a stress it is ill-equipped to tolerate if it has a TT genotype’ (Estkes 1998; Shields et al. 1999). Data from several areas of the world have shown that the thermolabile variant C677T is indeed associated with an increased risk of NTD but comparing with the prevalence of this mutation, it can only account for a small proportion (about 12%) of observed NTD (Morrison et al. 1998; Richter et al. 2001; De Marco et al. 2002). Data from most studies do not support a role for A1298C polymorphism in NTD, nor does it have a combined effect with C677T polymorphism (Parle-McDermott et al. 2003a). Search for defects in other genes controlling FA metabolism became necessary when MTHFR variants could not account for all or most of the 50–70% rescue effects attributed to periconceptional intake of FA on NTD.

Methylenetetrahydrofolate-dehydrogenase (MTHFD)

It is a trifunctional (methylenetetrahydrofolate-dehydrogenase, methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase) nicofinamide adenine dinucleotide phosphate (NADP)-dependent cytoplasmic enzyme (also referred to as C1-THF synthase), which catalyzes the conversion of tetrahydrofolate to the corresponding 10-formyl, 5, 10-methynyl, and 5, 10-methylene derivatives important for the de novo biosynthesis of purines and pyrimidines and thus DNA biosynthesis. A Dutch study on spina bifida patients and their parents could not obtain strong evidence in favor of a risk for NTD in patients homozygous for R293H and R653Q polymorphisms (Hol et al. 1998), whereas Brody et al. (2002) showed evidence for a role for the maternal genotypic MTHFD1 R653Q variant in abnormal neural tube development. In this instance, the case mother carries the risk genotype. This is an important observation that highlights not only the significance of FA-related genes, but also the influence of the maternal genotype on neural tube development. The differences in the data produced in geographically different parts of the world may be explained by not only the genetic characteristics of the populations studied but also the differences in their nutritional environment. Further work is needed to elucidate the complexity of this issue, because it still doesn’t account for the entire rescue property attributed to folate with regards to NTD.

Vitamin B12 and homocysteine

Even those NTD patients and their parents who are not homozygous or heterozygous for MTHFR C677T mutation have low plasma FA and elevated homocysteine levels (van der Put et al. 1997a). In fact mothers of NTD infants are only low in folate levels but not deficient. Therefore, in addition to low FA levels or polymorphisms in FA metabolizing enzymes, lower vitamin B12 (or cobalamin) concentrations during pregnancy may also be independently contributing to an increased risk for NTD (Kirke et al. 1993). Homocysteine (Hcy) is formed from demethylation of methionine. It can be irreversibly degraded into cystathionine and cysteine catalyzed by cystathionine β-synthase or remethylated into methionine by methionine synthase (MTR) or betaine-homocysteine methyl transferase (BHMT). Women carrying an NTD affected fetus have been observed to have mildly elevated Hcy concentrations in plasma and amniotic fluid, in response to methionine loading (Mills et al. 1995; Steegers-Theunissen et al. 1995). Plasma Hcy levels and NTD incidence are known to be determined by both genetic and nutritional factors. However, common variant alleles of the cystathionine β-synthase gene do not seem to constitute a definitive risk for NTD (Ramsbottom et al. 1997). Methionine synthase reductase (MTRR) is required to maintain the methionine synthase cofactor, methylcobalamin derived from vitamin B12 in an active state (Brody et al. 1999). Thus vitamin B12-dependent remethylation of homocysteine involves transcobalamin (TC), methionine synthase (MTR) and MTR reductase (MTRR). Mutations in these genes might be involved in elevation of total plasma homocysteine (tHcy) concentrations and in the causation of NTD. In a study of South Italian NTD patients, Gueant-Rodriguez et al. (2003) observed a strong association between MTR 2756 AG/GG, TC 777 CG/GG/MTHFR 677 CC and MTRR 66 GG/MTHFR 677 CC genotypes and increased risk for NTD. This study also indicates that genetic factors that can limit cellular availability or MTRR-dependent reduction of B12 may augment the risk of spina. bifida. Zhu et al. (2003) reported a similar association of polymorphisms of MTR and MTRR in a population along the US-Mexico border.

A recent study from northern UK, where a high frequency of NTD is known to occur indicates that the MTHFR 677C[RIGHTWARDS ARROW]T polymorphism constitutes a risk factor and that the MTRR 66[RIGHTWARDS ARROW]A G polymorphism exerts a protective effect in NTD cases. When statistical tests for interaction were performed, three genotype combinations in cases (MTRR/GCPII; MTHFR 677/CβS; MTHFR 677/MTRR) and one combination in case mothers (CβS/RFC-1) were found to elevate NTD risk. Maternal–fetal interaction was also detected when offspring carried the MTHFR 677C[RIGHTWARDS ARROW]T variant and mothers carried the MTRR 66A[RIGHTWARDS ARROW]G variant, resulting in a significant elevation of NTD risk. These data suggest that both independent genetic effects and gene–gene interaction play important roles in relation to NTD risk. It appears that multilocus rather than single locus analysis might provide an accurate measurement of genetic susceptibility to NTD (Relton et al. 2004). Studies on the Irish and Dutch NTD patients suggest that inherited variations in MTR and MTRR either alone or in combination with other folate enzyme polymorphisms are not associated with elevated NTD risk and that methionine synthase gene is not involved in the etiology of NTD (van der Put et al. 1997a,b; Brody et al. 1999; O’Leary et al. 2002; O’Leary et al. 2005). Conclusions have to wait further elucidation of the complex gene functions in FA metabolism. Methylmalonyl-CoA mutase is another B12-dependent enzyme which utilizes adenosylcobalamin to catalyze the isomerization of l-methylmalonyl-CoA to succinyl-CoA. Moderately elevated methylmalonic acid (MMA) in women carrying an NTD affected fetus has been reported (Adams et al. 1995). However common variations in the methylmalonyl-coA mutase are not found to be risk factors for NTD in an Irish study (Parle-McDermott et al. 2003b).

Folate carrier and folate receptor genes

Now that variants of the genes that code for the enzymes of the folate metabolic pathway could not account for all the 50–70% reduction in NTD incidence attributed to FA-supplementation, attention is turned to the hypothesis that individuals with defective FA absorption, transport and cellular internalization might be at increased risk for NTD. Folates are poorly transported across plasma membrane by diffusion. Reduced folate carrier (RFC) protein is expressed in the brush border of small intestinal epithelium and in hepatocytes. It preferentially mediates transport of reduced FA such as 5 methyltetrahydrofolate (MTF). RFC transcripts and proteins are expressed in the trophoblast, yolk sac, neuroepithelium, limb buds and cardiac primordium in mouse embryos (Maddox et al. 2003). Targeted mutation of RFC in the mouse results in fetal death at mid-gestation indicating its developmental importance (Zhao et al. 2001). FA receptor gene variants might impose a reduction in FA uptake by embryonic cell populations involved in neural tube development and thus confer an increased liability to NTD. Folate receptor genes occur as a family of paralogous glycoproteins: FR-α, FR-β, FR-χ and FR-δ. FR-α is described to possess the greatest affinity for 5-methyltetrahydrofolate, the physiological form of folic acid. The binding of 5-methyl tetrahydrofolate to a folate receptor is an important step in folate uptake and delivery into the cells by endocytosis. Expression of Folbp1 (folate binding protein-1, the mouse equivalent of human FR-α) is reported to follow a pattern by first being expressed at the initiation sites of neural fold fusion, particularly along the dorsal edges of neural folds as well as in the yolk sac thus suggesting a possible role in neural tube closure and materno-fetal transport of FA at the yolk sac (Piedrahita et al. 1999; Saitsu et al. 2003). Functional inactivation of Fbp1 and Fbp2 in mice shows that Fbp1 is important for embryo survival, neuroepithelial differentiation and fusion and neural crest migration and differentiation (Piedrahita et al. 1999). Mouse embryos, in which FBP1 has been knocked out, develop NTD and die at mid-gestation (Spiegelstein et al. 2004). Folb2–/–embryos develop normally. However, it should be pointed out here that the role of RFC and FBP in human neural tube closure has not been clarified as yet. Studies in European and US NTD populations have not established FR-α, or FR–β gene association with NTD (Barber et al. 1998; Heil et al. 1999; Trembath et al. 1999; O’Leary et al. 2003).

Other nutrients

Another nutrient important for proper functioning of many proteins, enzymes and transcription factors is Zinc (Zn). A relationship between Zn and NTD was demonstrated experimentally several years ago by Warkany and Petering (1972). Later several Zn-dependent transcription factors were shown to be risk factors for NTD in mouse models (Purandare et al. 2002). Maternal and offspring Zn and myo-inositol concentrations have been reported to be lower in human spina bifida (Groenen et al. 2003). However, a recent human study shows that genetic variants in ZIC1, ZIC2, and ZIC3 are not major risk factors for NTD (Klootwijk et al. 2004). It appears that Zn deficiency might act on vulnerable embryonic primordia via as yet unknown mechanisms and contribute to NTD in susceptible embryos. Realizing the importance of cholesterol biosynthesis in normal NTD development, some studies focussed on the genetic variations in the apoE and apoB genes, known to regulate cholesterol metabolism. The results did not show that these genes contribute substantially to the risk of spina bifida in infants (Volcik et al. 2002b).


  1. Top of page
  2. Abstract

The last three decades have seen a remarkable accumulation of clinical and experimental data in search of the causes, mechanisms and manifestations of neural tube malformations. However, due to the paucity of human embryos of early stages of neural tube development, our knowledge of the morphologic and molecular bases of normal development of human neural tube has remained limited. Neural tube defects have a narrow definition in the literature and do not include post closure defects with the exception of encephaloceles. Search for polymorphic genes that might contribute to NTD is largely limited to those known to be involved in FA pathway and none has been shown to play decisive roles in causing arrest of neural tube closure. It appears that gene-gene, gene-nutrient and gene-(non-nutrient) environment interactions might contribute to NTD. Future studies must be directed at unraveling the possible interaction or combinations of such interactions, prenatal medical and surgical correction of NTD and effective preventive strategies.


  1. Top of page
  2. Abstract

The author is grateful to John Wiley and Sons, Springer-Verlag and Lippincott Williams and Wilkins for kind permission for using concepts of the figures from O’Rahilly and Muller (2002); Nakatsu et al. (2000); Copp and Bernfield (1994), respectively. Ms. Ivanna Lizarriturri of our Media Unit painstakingly did the illustration from my sketches. Generous grants from the Faculty of Medicine and Health Sciences [Grant NP/04/15; NP/05/22] and from the UAE University [Grant ♯02-13-8-11/03; Grant ♯ 01-13-8-11/04] are gratefully appreciated.


  1. Top of page
  2. Abstract
  • Adams MJ Jr, Khoury MJ, Scanlon KS et al. (1995) Elevated midtrimester serum methylmalonic acid levels as a risk factor for neural tube defects. Teratology 51: 311317.
  • Ahdab-Barmada M, Claassen D (1990) A distinctive triad of malformations of the central nervous system in the Meckel–Gruber syndrome. J Neuropathol Exp Neurol 49: 610620.
  • Al-Gazali LI, Sztriha L, Dawodu A et al. (1999) Pattern of central nervous system anomalies in a population with a high rate of consanguineous marriages. Clin Genet 55: 95102.
  • Barber RC, Shaw GM, Lammer EJ et al. (1998) Lack of association between mutations in the folate receptor-alpha gene and spina bifida. Am J Med Genet 76: 310317.
  • Basch ML, Garcia-Castro MI, Bronner-Fraser M (2004) Molecular mechanisms of neural crest induction. Birth Defects Res Part C Embryo Today 72: 109123.
  • Blanco Munoz J, Lacasana M, Borja Aburto VH, Torres Sanchez LE, Garcia Garcia AM, Lopez Carrillo L (2005) Socioeconomic factors and the risk of anencephaly in a Mexican population: A case-control study. Public Health Rep 120: 3945.
  • Bove FJ, Fulcomer MC, Klotz JB, Esmart J, Dufficy EM, Savrin JE (1995) Public drinking water contamination and birth outcomes. Am J Epidemiol 141: 850862.
  • Bozinov O, Tirakotai W, Sure U, Bertalanffy H (2005) Surgical closure and reconstruction of a large occipital encephalocele without parenchymal excision. Childs Nerv Syst 21: 144147.
  • Brender JD, Suarez L (1990) Paternal occupation and anencephaly. Am J Epidemiol 131: 517521.
  • Brody LC, Baker PJ, Chines PS et al. (1999) Methionine synthase: High-resolution mapping of the human gene and evaluation as a candidate locus for neural tube defects. Mol Genet Metab 67: 324333.
  • Brody LC, Conley M, Cox C et al. (2002) A polymorphism, R653Q., in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: Report of the Birth Defects Research Group. Am J Hum Genet 71: 12071215.
  • Brook FA, Shum AS, Van Straaten HW, Copp AJ (1991) Curvature of the caudal region is responsible for failure of neural tube closure in the curly tail (ct) mouse embryo. Development 113: 671678.
  • Busby A, Abramsky L, Dolk H, Armstrong B (2005) Eurocat Folic Acid Working Group. Preventing neural tube defects in Europe: Population based study. BMJ 330: 574575.
  • Cabrera RM, Hill DS, Etheredge AJ, Finnell RH (2004) Investigations into the etiology of neural tube defects. Birth Defects Res Part C Embryo Today 72: 330344.
  • Campbell LR, Dayton DH, Sohal GS (1986) Studies on the etiology of neural tube defects. Teratology 34: 171187.
  • Carmi R, Gohar J, Meizner I, Katz M (1994) Spontaneous abortion – high risk factor for neural tube defects in subsequent pregnancy. Am J Med Genet 51: 9397.
  • Carter CO, David PA, Laurence KM (1968) A family study of major central nervous system malformations in South Wales. J Med Genet 5: 81106.
  • Catala M (2002) Genetic control of caudal development. Clin Genet 61: 8996.
  • Chan A, Pickering J, Haan E et al. (2001) ‘Folate before pregnancy’: The impact on women and health professionals of a population-based health promotion campaign in South Australia. Med J Aust 174: 631636.
  • Chiang C, Litingtung Y, Lee E et al. (1996) Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function. Nature 383: 407413.
  • Coerdt W, Miller K, Holzgreve W, Rauskolb R, Schwinger E, Rehder H (1997) Neural tube defects in chromosomally normal and abnormal human embryos. Ultrasound Obstet Gynecol 10: 410415.
  • Colas JF, Schoenwolf GC (2001) Towards a cellular and molecular understanding of neurulation. Dev Dyn 221: 117145.
  • Colas JF, Schoenwolf GC (2003) Assessing the contributions of gene products to the form-shaping events of neurulation: A transgenic approach in chick. Genesis 37: 6475.
  • Committee on Developmental Toxicology, National Research Council (2000) Scientific Frontiers in Developmental Toxicology and Risk Assessment. National Academic Press, Washington, DC.
  • Copp AJ, Bernfield M (1994) Etiology and pathogenesis of human neural tube defects: Insights from mouse models. Curr Opin Pediatr 6: 624631.
  • Copp AJ, Greene ND, Murdoch JN (2003) The genetic basis of mammalian neurulation. Nat Rev Genet 4: 784793.
  • Croen LA, Shaw GM, Sanbonmatsu L, Selvin S, Buffler PA (1997) Maternal residential proximity to hazardous waste sites and risk for selected congenital malformations. Epidemiology 8: 347354.
  • Czeizel AE, Dudas I (1992) Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med 327: 18321835.
  • Czeizel A, Metneki J (1984) Recurrence risk after neural tube defects in a genetic counselling clinic. J Med Genet 21: 413416.
  • Davies BR, Duran M (2003) Malformations of the cranium, vertebral column, and related central nervous system: Morphologic heterogeneity may indicate biological diversity. Birth Defects Res Part A Clin Mol Teratol 67: 563571.
  • De Marco P, Calevo MG, Moroni A et al. (2002) Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population. J Hum Genet 47: 319324.
  • Demenais F, Le Merrer M, Briard ML, Elston RC (1982) Neural tube defects in France: Segregation analysis. Am J Med Genet 11: 287298.
  • Dias MS, Partington M (2004) Embryology of myelomeningocele and anencephaly. Neurosurg Focus 16: E1.
  • Dietl J (2005) Maternal obesity and complications during pregnancy. J Perinat Med 33: 100105.
  • Dolk H, Vrijheid M, Armstrong B et al. (1998) Risk of congenital anomalies near hazardous-waste landfill sites in Europe: The EUROHAZCON study. Lancet 352: 423427.
  • Doudney K, Stanier P (2005) Epithelial cell polarity genes are required for neural tube closure. Am J Med Genet C Semin Med Genet 135: 4247.
  • Edwards MJ (1968) The external development of the rabbit and rat embryo. Adv Teratol 3: 239263.
  • Edwards MJ, Saunders RD, Shiota K (2003) Effects of heat on embryos and fetuses. Int J Hyperthermia 19: 295324.
  • Edwards MJ, Shiota K, Smith MS, Walsh DA (1995) Hyperthermia and birth defects. Reprod Toxicol 9: 411425.
  • Estkes TKAB (1998) Neural tube defects, vitamins and homocysteine. Eur J Pediatr 157: S130S141.
  • EUROCAT Working Group (1991) Prevalence of neural tube defects in 20 regions of Europe and the impact of prenatal diagnosis, 1980–1986. J Epidemiol Community Health 45: 5258.
  • Farlie PG, McKeown SJ, Newgreen DF (2004) The neural crest: Basic biology and clinical relationships in the craniofacial and enteric nervous systems. Birth Defects Res Part C Embryo Today 72: 173189.
  • Felder B, Stegmann K, Schultealbert A et al. (2002) Evaluation of BMP4 and its specific inhibitor NOG as candidates in human neural tube defects (NTDs). Eur J Hum Genet 10: 753756.
  • Fineman RM, Jorde LB, Martin RA, Hasstedt SJ, Wing SD, Walker ML (1982) Spinal dysraphia as an autosomal dominant defect in four families. Am J Med Genet 12: 457464.
  • Finnell RH, Shaw GM, Lammer EJ, Brandl KL, Carmichael SL, Rosenquist TH (2004) Gene–nutrient interactions: Importance of folates and retinoids during early embryogenesis. Toxicol Appl Pharmacol 198: 7585.
  • Fleming A, Copp AJ (2000) A genetic risk factor for mouse neural tube defects: Defining the embryonic basis. Hum Mol Genet 9: 575581.
  • Fleming A, Gerrelli D, Greene ND, Copp AJ (1997) Mechanisms of normal and abnormal neurulation: Evidence from embryo culture studies. Int J Dev Biol 41: 199212.
  • Frey L, Hauser WA (2003) Epidemiology of neural tube defects. Epilepsia 44 (Suppl. 3): 413.
  • Gammill LS, Bronner-Fraser M (2002) Genomic analysis of neural crest induction. Development 129: 57315741.
  • Gammill LS, Bronner-Fraser M (2003) Neural crest specification into genomic. Nat Rev Neurosci 4: 795805.
  • Garabedian BH, Fraser FC (1994) A familial association between twinning and upper-neural tube defects. Am J Hum Genet 55: 10501053.
  • Gardner WJ (1980) Hypothesis; overdistention of the neural tube may cause anomalies of non-neural organs. Teratology 22: 229238.
  • Garne E, Loane M, Dolk H et al. (2005) Prenatal diagnosis of severe structural congenital malformations in Europe. Ultrasound Obstet Gynecol 25: 611.
  • Golden JA, Chernoff GF (1993) Intermittent pattern of neural tube closure in two strains of mice. Teratology 47: 7380.
  • Groenen PM, Peer PG, Wevers RA et al. (2003) Maternal myo-inositol, glucose, and zinc status is associated with the risk of offspring with spina bifida. Am J Obstet Gynecol 189: 17131719.
  • Gueant-Rodriguez RM, Rendeli C, Namour B et al. (2003) Transcobalamin and methionine synthase reductase mutated polymorphisms aggravate the risk of neural tube defects in humans. Neurosci Lett 344: 189192.
  • Harris MJ (2001) Why are the genes that cause risk of human neural tube defects so hard to find? Teratology 63: 165166.
  • Harris RZ, Jang GR, Tsunoda S (2003) Dietary effects on drug metabolism and transport. Clin Pharmacokinet 42: 10711088.
  • Heil SG, Van Der Put NM, Trijbels FJ, Gabreels FJ, Blom HJ (1999) Molecular genetic analysis of human folate receptors in neural tube defects. Eur J Hum Genet 7: 393396.
  • Hildebrand JD, Soriano P (1999) Shroom, a PDZ domain-containing actin-binding protein, is required for neural tube morphogenesis in mice. Cell 99: 485497.
  • Hol FA, Van Der Put NM, Geurds MP et al. (1998) Molecular genetic analysis of the gene encoding the trifunctional enzyme MTHFD methenyltetrahydrofolate-cyclohydrolase, formyltetrahydrofolate synthetase) in patients with neural tube defects. Clin Genet 53: 119125.
  • Ikenouchi J, Uwabe C, Nakatsu T, Hirose M, Shiota K (2002) Embryonic hydromyelia: Cystic dilatation of the lumbosacral neural tube in human embryos. Acta Neuropathol (Berl) 103: 248254.
  • Jessell TM, Sanes JR (2000) Development. The decade of the developing brain. Curr Opin Neurobiol 10: 599611.
  • Juriloff DM, Harris MJ (2000) Mouse models for neural tube closure defects. Hum Mol Genet 9: 9931000.
  • Juriloff DM, Harris MJ, Tom C, MacDonald KB (1991) Normal mouse strains differ in the site of initiation of closure of the cranial neural tube. Teratology 44: 225233.
  • Kallen B, Robert E, Harris J (1998) Associated malformations in infants and fetuses with upper or lower neural tube defects. Teratology 57: 5663.
  • Kirke PN, Molloy AM, Daly LE, Burke H, Weir DG, Scott JM (1993) Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med 86: 703708.
  • Klootwijk R, Schijvenaars MM, Mariman EC, Franke B (2004) Further characterization of the genetic defect of the Bent tail mouse, a mouse model for human neural tube defects. Birth Defects Res Part A Clin Mol Teratol 70: 880884.
  • Knecht AK, Bronner-Fraser M (2002) Induction of the neural crest: A multigene process. Nat Rev Genet 3: 453461.
  • Laurence KM, Carter CO, David PA (1968) Major central nervous system malformations in South Wales. II. Pregnancy factors, seasonal variation, and social class effects. Br J Prev Soc Med 22: 212222.
  • Lawson A, Anderson H, Schoenwolf GC (2001) Cellular mechanisms of neural fold formation and morphogenesis in the chick embryo. Anat Rec 262: 153168.
  • Lee J, Platt KA, Censullo P, Ruiz i Altaba A (1997) Gli1 is a target of Sonic hedgehog that induces ventral neural tube development. Development 124: 25372552.
  • Lemire RJ (1988a) Neural tube defects. JAMA 259: 558562.
  • Lemire RJ (1988b) Neural tube defects. J Child Neurol 3: 246.
  • Li Z, Gindler J, Wang H et al. (2003) Folic acid supplements during early pregnancy and likelihood of multiple births: A population-based cohort study. Lancet 361: 380384.
  • Linker C, Stern CD (2004) Neural induction requires BMP inhibition only as a late step, and involves signals other than FGF and Wnt antagonists. Development 131: 56715681.
  • Maddox DM, Manlapat A, Roon P, Prasad P, Ganapathy V, Smith SB (2003) Reduced-folate carrier (RFC) is expressed in placenta and yolk sac, as well as in cells of the developing forebrain, hindbrain, neural tube, craniofacial region, eye, limb buds and heart. BMC Dev Biol 3: 6.
  • Manning N, Archer N (2001) Treatment and outcome of serious structural congenital heart disease. Semin Neonatol 6: 3747.
  • Marin-Padilla M (1970) The closure of the neural tube in the golden hamster. Teratology 3: 3945.
  • Marin-Padilla M (1991) Cephalic axial skeletal-neural dysraphic disorders: Embryology and pathology. Can J Neurol Sci 18: 153169.
  • Marshall EG, Gensburg LJ, Deres DA, Geary NS, Cayo MR (1997) Maternal residential exposure to hazardous wastes and risk of central nervous system and musculoskeletal birth defects. Arch Environ Health 52: 416425.
  • Martinez-Frias ML, Urioste M, Bermejo E, Sanchis A, Rodriguez-Pinilla E (1996) Epidemiological analysis of multi-site closure failure of neural tube in humans. Am J Med Genet 66: 6468.
  • Matte TD, Mulinare J, Erickson JD (1993) Case-control study of congenital defects and parental employment in health care. Am J Ind Med 24: 1123.
  • McDonnell RJ, Johnson Z, Delaney V, Dack P (1999) East Ireland 1980–94: Epidemiology of neural tube defects. J Epidemiol Community Health 53: 782788.
  • McFadden DE, Friedman JM (1997) Chromosome abnormalities in human beings. Mutat Res 396: 129140.
  • McLone DG, Dias MS (2003) The Chiari II malformation: Cause and impact. Childs Nerv Syst 19: 540550.
  • Mills JL, McPartlin JM, Kirke PN et al. (1995) Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 345: 149151.
  • Moretti ME, Bar-Oz B, Fried S, Koren G (2005) Maternal hyperthermia and the risk for neural tube defects in offspring: Systematic review and meta-analysis. Epidemiology 16: 216219.
  • Morgagni JB (1769) The Seats and Causes of Diseases as Investigated by Anatomy. 3 volumes, Translated by Benjamin Alexander. Miller & T Candell Publishers, London.
  • Morris SE, Thomson AO, Jarup L, De Hoogh C, Briggs DJ, Elliott P (2003) No excess risk of adverse birth outcomes in populations living near special waste landfill sites in Scotland. Scott Med J 48: 105107.
  • Morrison K, Papapetrou C, Hol FA et al. (1998) Susceptibility to spina bifida; an association study of five candidate genes. Ann Hum Genet 62: 379396.
  • MRC Vitamin Study Research Group (1991) Prevention of neural tube defects: Results of the medical research council vitamin study. Lancet 338: 131137.
  • Muller F, O’Rahilly R (1987) The development of the human brain, the closure of the caudal neuropore, and the beginning of secondary neurulation at stage 12. Anat Embryol (Berl) 176: 413430.
  • Murdoch JN, Henderson DJ, Doudney K et al. (2003) Disruption of scribble (Scrb1) causes severe neural tube defects in the circletail mouse. Hum Mol Genet 12: 8798.
  • Nakatsu T, Uwabe C, Shiota K (2000) Neural tube closure in humans initiates at multiple sites: Evidence from human embryos and implications for the pathogenesis of neural tube defects. Anat Embryol (Berl) 201: 455466.
  • Nishimura H, Uwabe C, Shiota K (1987) Study of human post-implantation conceptuses, normal and abnormal. Okajimas Folia Anat Jpn 63: 337357.
  • Nye JS, Balkin N, Lucas H, Knepper PA, McLone DG, Charrow J (1998) Myelomeningocele and Waardenburg syndrome (type 3) in patients with interstitial deletions of 2q35 and the PAX3 gene: Possible digenic inheritance of a neural tube defect. Am J Med Genet 75: 401408.
  • O’Leary VB, Mills JL, Kirke PN et al. (2003) Analysis of the human folate receptor beta gene for an association with neural tube defects. Mol Genet Metab 79: 129133.
  • O’Leary VB, Mills JL, Pangilinan F et al. (2005) Analysis of methionine synthase reductase polymorphisms for neural tube defects risk association. Mol Genet Metab 85: 220227.
  • O’Leary VB, Parle-McDermott A, Molloy AM et al. (2002) MTRR and MTHFR polymorphism: Link to Down syndrome? Am J Med Genet 107: 151155.
  • O’Rahilly R, Muller F (1988) Neuroschisis in human embryos. Teratology 38: 189.
  • O’Rahilly R, Muller F (1989) Interpretation of some median anomalies as illustrated by cyclopia and symmelia. Teratology 40: 409421.
  • O’Rahilly R, Muller F (1994) Neurulation in the normal human embryo. Ciba Found Symp 181: 7082;discussion 82–89.
  • O’Rahilly R, Muller F (2002) The two sites of fusion of the neural folds and the two neuropores in the human embryo. Teratology 65: 162170.
  • Padmanabhan R (1984) Experimental induction of cranioschisis aperta and exencephaly after neural tube closure – A rat model. J Neurol Sci 66: 235243.
  • Padmanabhan R (1988) Light microscopic studies on the pathogenesis of exencephaly and cranioschisis induced in the rat after neural tube closure. Teratology 37: 2936.
  • Padmanabhan R (1989) Pathogenesis of exencephaly and cranioschisis induced in the rat after neural tube closure: Role of the mesenchyme. J Craniofac Genet Dev Biol 9: 239255.
  • Padmanabhan R (1990a) Electron microscopic studies on the pathogenesis of exencephaly and cranioschisis induced in the rat after neural tube closure: Role of the neuroepithelium and choroid plexus. Acta Anat 137: 518.
  • Padmanabhan R (1990b) Scanning electron microscopic studies on the pathogenesis of exencephaly and cranioschisis induced in the rat after neural tube closure. Acta Anat 138: 97110.
  • Padmanabhan R (1998) Retinoic acid–induced caudal regression syndrome in the mouse fetus. Reprod Toxicol 12: 139151.
  • Padmanabhan R, Al-Zuhair AGH (1988) Congenital malformation and intrauterine growth retardation in streptozotocin induced diabetes during gestation in the rat. Reprod Toxicol 1: 117125.
  • Padmanabhan R, Hameed MS (1985) Malformations of the axial skeleton in cranioschisis aperta and exencephaly in rat fetuses induced after neural tube closure. Virchow’s Arch Path Anat 408: 6173.
  • Papp C, Adam Z, Toth-Pal E, Torok O, Varadi V, Papp Z (1997) Risk of recurrence of craniospinal anomalies. J Matern Fetal Med 6: 5357.
  • Parle-McDermott A, Mills JL, Kirke PN et al. (2003a) Analysis of the MTHFR 1298A[RIGHTWARDS ARROW]C and 677C[RIGHTWARDS ARROW]T polymorphisms as risk factors for neural tube defects. J Hum Genet 48: 190193.
  • Parle-McDermott A, McManus EJ et al.; Birth Defects Research Group (2003b) Polymorphisms within the vitamin B12 dependent methylmalonyl-CoA mutase are not risk factors for neural tube defects. Mol Genet Metab 80: 463468.
  • Pasteris NG, Trask BJ, Sheldon S, Gorski JL (1993) Discordant phenotype of two overlapping deletions involving the PAX3 gene in chromosome 2q35. Hum Mol Genet 2: 953959.
  • Peeters MC, Hekking JW, Shiota K, Drukker J, Van Straaten HW (1998) Differences in axial curvature correlate with species-specific rate of neural tube closure in embryos of chick, rabbit, mouse, rat and human. Anat Embryol (Berl) 198: 185194.
  • Petrini J, Damus K, Russell R, Poschman K, Davidoff MJ, Mattison D (2002) Contribution of birth defects to infant mortality in the United States. Teratology 66: S3S6.
  • Piedrahita JA, Oetama B, Bennett GD et al. (1999) Mice lacking the folic acid-binding protein Folbp1 are defective in early embryonic development. Nat Genet 23: 228232.
  • Pinar H (2004) Postmortem findings in term neonates. Semin Neonatol 9: 289302.
  • Purandare SM, Ware SM, Kwan KM et al. (2002) A complex syndrome of left-right axis, central nervous system, and axial skeleton defects in Zic3 mutant mice. Development 129: 22932302.
  • Ramsbottom D, Scott JM, Molloy A et al. (1997) Are common mutations of cystathionine beta-synthase involved in the etiology of neural tube defects? Clin Genet 51: 3942.
  • Ray JG, Vermeulen MJ, Meier C, Wyatt PR (2004) Risk of congenital anomalies detected during antenatal serum screening in women with pregestational diabetes. QJM 97: 651653.
  • Relton CL, Wilding CS, Pearce MS et al. (2004) Gene–gene interaction in folate-related genes and risk of neural tube defects in a UK population. J Med Genet 41: 256260.
  • Richter B, Stegmann K, Roper B, Boddeker I, Ngo ET, Koch MC (2001) Interaction of folate and homocysteine pathway genotypes evaluated in susceptibility to neural tube defects (NTD) in a German population. J Hum Genet 46: 105109.
  • Rintoul NE, Sutton LN, Hubbard AM et al. (2002) A new look at myelomeningoceles: Functional level, vertebral level, shunting, and the implications for fetal intervention. Pediatrics 109: 409413.
  • Ruiz i Altaba A (1998) Combinatorial Gli gene function in floor plate and neuronal inductions by Sonic hedgehog. Development 125: 22032212.
  • Saitsu H, Ishibashi M, Nakano H, Shiota K (2003) Spatial and temporal expression of folate-binding protein 1 (Fbp1) is closely associated with anterior neural tube closure in mice. Dev Dyn 226: 112117.
  • Saitsu H, Yamada S, Uwabe C, Ishibashi M, Shiota K (December 2004) Development of the posterior neural tube in human embryos. Anat Embryol (Berl) 209: 107117.
  • Sakai Y (1989) Neurulation in the mouse: Manner and timing of neural tube closure. Anat Rec 223: 194203.
  • Schaefer-Graf UM, Buchanan TA, Xiang A, Songster G, Montoro M, Kjos SL (2000) Patterns of congenital anomalies and relationship to initial maternal fasting glucose levels in pregnancies complicated by type 2 and gestational diabetes. Am J Obstet Gynecol 182: 313320.
  • Schoenwolf GC (2001) Cutting, pasting and painting: Experimental embryology and neural development. Nat Rev Neurosci 2: 763771.
  • Schoenwolf GC, Smith JL (2000) Mechanisms of neurulation. Methods Mol Biol 136: 125134.
  • Sebold CD, Melvin EC, Siegel D et al. (2005) NTD Collaborative Group Recurrence risks for neural tube defects in siblings of patients with lipomyelomeningocele. Genet Med 7: 6467.
  • Seller MJ (1995) Sex, neural tube defects, and multisite closure of the human neural tube. Am J Med Genet 58: 332336.
  • Seller MJ, Kalousek DK (1986) Neural tube defects: Heterogeneity and homogeneity. Am J Med Genet Suppl 2: 7787.
  • Sever LE (1995) Looking for causes of neural tube defects: Where does the environment fit in? Environ Health Perspect 103 (Suppl. 6): 165171.
  • Shaffer LG, Marazita ML, Bodurtha J, Newlin A, Nance WE (1990) Evidence for a major gene in familial anencephaly. Am J Med Genet 36: 97101.
  • Shaw GM, Nelson V, Olshan AF (2002) Paternal occupational group and risk of offspring with neural tube defects. Paediatr Perinat Epidemiol 16: 328333.
  • Shenefelt RE (1972) Morphogenesis of malformations in hamsters caused by retinoic acid: Relation to dose and stage at treatment. Teratology 5: 103118.
  • Shepard TH, Brent RL, Friedman JM et al. (2002) Update on new developments in the study of human teratogens. Teratology 65: 153161.
  • Shields DC, Kirke PN, Mills JL et al. (1999) The ‘thermolabile’ variant of methylenetetrahydrofolate reductase and neural tube defects: An evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am J Hum Genet 64: 10451055.
  • Shiota K, Uwabe C, Nishimura H (1987) High prevalence of defective human embryos at the early postimplantation period. Teratology 35: 309316.
  • Shum AS, Poon LL, Tang WW et al. (1999) Retinoic acid induces down-regulation of Wnt-3a, apoptosis and diversion of tail bud cells to a neural fate in the mouse embryo. Mech Dev 84: 1730.
  • Smith JL, Schoenwolf GC, Quan J (1994) Quantitative analyses of neuroepithelial cell shapes during bending of the mouse neural plate. J Comp Neurol 342: 144151.
  • Spiegelstein O, Mitchell LE, Merriweather MY et al. (2004) Embryonic development of folate binding protein-1 (Folbp1) knockout mice: Effects of the chemical form, dose, and timing of maternal folate supplementation. Dev Dyn 231: 221231.
  • Stamataki D, Ulloa F, Tsoni SV, Mynett A, Briscoe J (2005) A gradient of Gli activity mediates graded Sonic Hedgehog signaling in the neural tube. Genes Dev 19: 626641.
  • Steegers-Theunissen RP, Boers GH, Blom HJ et al. (1995) Neural tube defects and elevated homocysteine levels in amniotic fluid. Am J Obstet Gynecol 172: 14361441.
  • Stevenson RE, Allen WP, Pai GS et al. (2000) Decline in prevalence of neural tube defects in a high-risk region of the United States. Pediatrics 106: 677683.
  • Van Straaten HW, Peeters MC, Hekking JW, Van Der Lende T (2000) Neurulation in the pig embryo. Anat Embryol (Berl) 202: 7584.
  • Suarez L, Felkner M, Hendricks K (2004) The effect of fever, febrile illnesses, and heat exposures on the risk of neural tube defects in a Texas-Mexico border population. Birth Defects Res Part A Clin Mol Teratol 70: 815819.
  • Sulik KK, Sadler TW (1993) Postulated mechanisms underlying the development of neural tube defects. Insights from in vitro and in vivo studies. Ann N Y Acad Sci 678: 821.
  • Theriault G, Iturra H, Gingras S (1983) Evaluation of the association between birth defects and exposure to ambient vinyl chloride. Teratology 27: 359370.
  • Torban E, Kor C, Gros P (2004) Van Gogh-like2 (Strabismus) and its role in planar cell polarity and convergent extension in vertebrates. Trends Genet 20: 570577.
  • Trembath D, Sherbondy AL, Vandyke DC et al. (1999) Analysis of select folate pathway genes, PAX3, and human T in a midwestern neural tube defect population. Teratology 59: 331341.
  • Uzych L (1988) Human male exposure to vinyl chloride and possible teratogenic and mutagenic risks: A review. Hum Toxicol 7: 517527.
  • Van Allen MI (1996) Multisite neural tube closure in humans. Birth Defects Orig Arctic Ser 30: 203225.
  • Van Allen MI, Kalousek DK, Chernoff GF et al. (1993) Evidence for multi-site closure of the neural tube in humans. Am J Med Genet 47: 723743.
  • Van Der Put NM, Steegers-Theunissen RP, Frosst P et al. (1995) Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet 346: 10701071.
  • Van Der Put NM, Thomas CM, Eskes TK et al. (1997a) Altered folate and vitamin B12 metabolism in families with spina bifida offspring. QJM 90: 505510.
  • Van Der Put NM, Van Der Molen EF, Kluijtmans LA et al. (1997b) Sequence analysis of the coding region of human methionine synthase: Relevance to hyperhomocysteinaemia in neural-tube defects and vascular disease. QJM 90: 511517.
  • Van Straaten HW, Janssen HC, Peeters MC, Copp AJ, Hekking JW (1996) Neural tube closure in the chick embryo is multiphasic. Dev Dyn 207: 309318.
  • Volcik KA, Blanton SH, Kruzel MC et al. (2002a) Testing for genetic associations in a spina bifida population: Analysis of the HOX gene family and human candidate gene regions implicated by mouse models of neural tube defects. Am J Med Genet 110: 203207.
  • Volcik KA, Zhu H, Shaw GM, Lammer EJ, Finnell RH (2002b) Apolipoprotein E and apolipoprotein B genotypes and risk for spina bifida. Teratology 66: 257259.
  • Von Recklinghausen F (1886) Untersuchungen uber die spina bifida. Virchows Arch [Path Anat] 105: 243373.
  • Vrijheid M, Dolk H, Armstrong B et al. (2002) EUROHAZCON collaborative group. Hazard potential ranking of hazardous waste landfill sites and risk of congenital anomalies. Occup Environ Med 59: 768776.
  • Wallingford JB, Fraser SE, Harland RM (2002) Convergent extension: The molecular control of polarized cell movement during embryonic development. Dev Cell 2: 695706.
  • Warkany J, Petering HG (1972) Congenital malformations of the central nervous system in rats produced by maternal zinc deficiency. Teratology 5: 319334.
  • Webb SE, Moreau M, Leclerc C, Miller AL (2005) Calcium transients and neural induction in vertebrates. Cell Calcium 37: 375385.
  • De Weerd S, Polder JJ, Cohen-Overbeek TE, Zimmermann LJ, Steegers EA (2004) Preconception care: Preliminary estimates of costs and effects of smoking cessation and folic acid supplementation. J Reprod Med 49: 338344.
  • Whitehead AS, Gallagher P, Mills JL et al. (1995) A genetic defect in 5, 10 methylenetetrahydrofolate reductase in neural tube defects. QJM 88: 763766.
  • Williams LJ, Rasmussen SA, Flores A, Kirby RS, Edmonds LD (2005) Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995–2002. Pediatrics 116: 580586.
  • Wilson JG (1973) Environment and Birth Defects. Academic Press, New York.
  • Windham GC, Sever LE (1982) Neural tube defects among twin births. Am J Hum Genet 34: 988998.
  • Wong WY, Merkus HM, Thomas CM, Menkveld R, Zielhuis GA, Steegers-Theunissen RP (2002) Effects of folic acid and zinc sulfate on male factor subfertility: A double-blind, randomized, placebo-controlled trial. Fertil Steril 77: 491498.
  • Xiao KZ, Zhang ZY, Su YM et al. (1990) Central nervous system congenital malformations, especially neural tube defects in 29 provinces, metropolitan cities and autonomous regions of China: Chinese birth defects monitoring program. Int J Epidemiol 19: 978982.
  • Ybot-Gonzalez P, Cogram P, Gerrelli D, Copp AJ (2002) Sonic hedgehog and the molecular regulation of mouse neural tube closure. Development 129: 25072517.
  • Zhao R, Russell RG, Wang Y et al. (2001) Rescue of embryonic lethality in reduced folate carrier-deficient mice by maternal folic acid supplementation reveals early neonatal failure of hematopoietic organs. J Biol Chem 276: 1022410228.
  • Zhu H, Wicker NJ, Shaw GM et al. (2003) Homocysteine remethylation enzyme polymorphisms and increased risks for neural tube defects. Mol Genet Metab 78: 216221.
  • Zlotogora J (1995) Major gene is responsible for anencephaly among Iranian Jews. Am J Med Genet 56: 87879.
  • Zlotogora J (1997a) Genetic disorders among Palestinian Arabs: 1. Effects of consanguinity. Am J Med Genet 68: 472475.
  • Zlotogora J (1997b) Genetic disorders among Palestinian Arabs: 2. Hydrocephalus and neural tube defects. Am J Med Genet 71: 3335.